Pasithea Therapeutics Corp.
KTTA
$0.57
-$0.03-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.29M | -19.73M | -20.43M | -13.49M | -13.46M |
| Total Depreciation and Amortization | 654.10K | 657.70K | 662.60K | 667.40K | 648.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.68M | 3.44M | 4.87M | 321.40K | 430.60K |
| Change in Net Operating Assets | -827.30K | -1.31M | -318.50K | 248.20K | -109.70K |
| Cash from Operations | -17.78M | -16.94M | -15.21M | -12.26M | -12.49M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 11.00K | 11.00K | 11.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 11.00K | 11.00K | 11.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 179.30K | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 56.47M | 62.31M | 63.97M | 7.51M | 7.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -155.40K | -448.20K | -448.20K | -432.80K | 4.22M |
| Cash from Financing | 56.31M | 62.05M | 63.52M | 7.07M | 11.73M |
| Foreign Exchange rate Adjustments | 4.00K | 46.90K | 18.80K | 46.40K | 6.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.55M | 45.16M | 48.34M | -5.14M | -750.50K |